CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- 424B2 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 1,542,857 shares at $3.50 ($5,400,000)
- 4 Open-market buy 10% owner bought 2,857,142 shares at $3.50 ($9,999,997)
- 4 Open-market buy 10% owner bought 400,000 shares at $3.50 ($1,400,000)
- D Other Notice of Sales of Unregistered Securities
Page 3 of 22 · 427 filings